Literature DB >> 19118912

Cost of medical care among type 2 diabetic patients with a co-morbid condition--hypertension in India.

Shabana Tharkar1, Kumpatla Satyavani, Vijay Viswanathan.   

Abstract

The aim was to estimate the cost of medical care among hospitalized diabetic patients and to assess the influence of an additional co-morbid condition-hypertension. A pre tested and validated questionnaire was interviewer administered among 443 (male:female, 235:208) hospitalized diabetic patients. The JNC VII criteria for hypertension was considered to divide the study population into two groups; group I - diabetic patients without hypertension (n=269) and group II - diabetic patients with hypertension (n=174). Details of cost of inpatient and out-patient care and expenditure on hospitalization for the previous 2 years were obtained. The prevalence of hypertension among the study subjects was 39.3% (174 subjects). Presence of hypertension made a significant impact on the expenditure pattern. On an average a diabetic patient with hypertension spent 1.4 times more than a diabetic subject without hypertension. Median cost per hospitalization, length of stay during admission, and cost of 2 years for inpatient admission were all significantly higher for diabetic patients with a co-morbid condition. There is a need to develop a protocol on cost effective strategy for diabetes care. Strict control of hypertension should be targeted to avoid excess treatment cost on diabetes care.

Entities:  

Mesh:

Year:  2008        PMID: 19118912     DOI: 10.1016/j.diabres.2008.11.027

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  12 in total

Review 1.  Prevalence of type 2 diabetes and its complications in India and economic costs to the nation.

Authors:  R Pradeepa; V Mohan
Journal:  Eur J Clin Nutr       Date:  2017-04-19       Impact factor: 4.016

Review 2.  Economic Impact of Diabetes in South Asia: the Magnitude of the Problem.

Authors:  Kavita Singh; K M Venkat Narayan; Karen Eggleston
Journal:  Curr Diab Rep       Date:  2019-05-16       Impact factor: 4.810

3.  Prevalence of Diabetes Mellitus and Its Risk Factors among Permanently Settled Tribal Individuals in Tribal and Urban Areas in Northern State of Sub-Himalayan Region of India.

Authors:  Dhiraj Kapoor; Ashok Kumar Bhardwaj; Dinesh Kumar; Sunil Kumar Raina
Journal:  Int J Chronic Dis       Date:  2014-05-06

Review 4.  Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review.

Authors:  Ann D Colosia; Roberto Palencia; Shahnaz Khan
Journal:  Diabetes Metab Syndr Obes       Date:  2013-09-17       Impact factor: 3.168

5.  The prevalence and determinants of catastrophic health expenditures attributable to non-communicable diseases in low- and middle-income countries: a methodological commentary.

Authors:  Yevgeniy Goryakin; Marc Suhrcke
Journal:  Int J Equity Health       Date:  2014-11-07

Review 6.  The economic burden of diabetes in India: a review of the literature.

Authors:  Charles A K Yesudian; Mari Grepstad; Erica Visintin; Alessandra Ferrario
Journal:  Global Health       Date:  2014-12-02       Impact factor: 4.185

7.  Resource use associated with type 2 diabetes in Africa, the Middle East, South Asia, Eurasia and Turkey: results from the International Diabetes Management Practice Study (IDMPS).

Authors:  Juan J Gagliardino; Petar K Atanasov; Juliana C N Chan; Jean C Mbanya; Marina V Shestakova; Prisca Leguet-Dinville; Lieven Annemans
Journal:  BMJ Open Diabetes Res Care       Date:  2017-01-17

Review 8.  Economic menace of diabetes in India: a systematic review.

Authors:  Sumit Oberoi; Pooja Kansra
Journal:  Int J Diabetes Dev Ctries       Date:  2020-06-17

9.  Rationale and protocol for estimating the economic value of a multicomponent quality improvement strategy for diabetes care in South Asia.

Authors:  Kavita Singh; Mohammed K Ali; Raji Devarajan; Roopa Shivashankar; Dimple Kondal; Vamadevan S Ajay; V Usha Menon; Premlata K Varthakavi; Vijay Viswanathan; Mala Dharmalingam; Ganapati Bantwal; Rakesh Kumar Sahay; Muhammad Qamar Masood; Rajesh Khadgawat; Ankush Desai; Dorairaj Prabhakaran; K M Venkat Narayan; Victoria L Phillips; Nikhil Tandon
Journal:  Glob Health Res Policy       Date:  2019-03-18

Review 10.  Provider costs for prevention and treatment of cardiovascular and related conditions in low- and middle-income countries: a systematic review.

Authors:  Elizabeth D Brouwer; David Watkins; Zachary Olson; Jane Goett; Rachel Nugent; Carol Levin
Journal:  BMC Public Health       Date:  2015-11-26       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.